Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 03:29 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Director | Pharmaceutical Preparations | OPT+S | $8.43 | 4,557 | $38,416 | 13,356 | -25.4% |
| 2020-12-17 00:41 | 2020-12-15 | BDSI | N/A | Bailey Jeffrey Allen | Director, Officer; Chief Executive Officer | Other | SALE | $4.35 | 10,000 | $43,500 | 35,567 | -21.9% |
| 2020-09-23 22:57 | 2020-09-23 | THW | abrdn World Healthcare Fund | Bailey Jeffrey Allen | Director | Other | BUY | $14.18 | 710 | $10,068 | 710 | +100.0% |
| 2020-09-23 22:57 | 2020-09-23 | THQ | abrdn Healthcare Opportunities Fund | Bailey Jeffrey Allen | Director | Other | BUY | $17.68 | 570 | $10,078 | 570 | +100.0% |
| 2020-09-23 22:56 | 2020-09-23 | HQH | abrdn Healthcare Investors | Bailey Jeffrey Allen | Director | Other | BUY | $20.39 | 490 | $9,991 | 490 | +100.0% |
| 2020-09-23 22:56 | 2020-09-22 | HQL | abrdn Life Sciences Investors | Bailey Jeffrey Allen | Director | Other | BUY | $17.28 | 580 | $10,022 | 580 | +100.0% |
| 2019-11-19 00:15 | 2019-11-14 | ALRN | Rein Therapeutics, Inc. | Bailey Jeffrey Allen | Director | Pharmaceutical Preparations | BUY | $0.51 | 55,000 | $28,050 | 74,894 | +276.5% |
| 2019-11-15 00:23 | 2019-11-12 | ALRN | Rein Therapeutics, Inc. | Bailey Jeffrey Allen | Director | Pharmaceutical Preparations | BUY | $0.53 | 19,894 | $10,544 | 19,894 | +100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.